Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Nova Mentis Life Science Corp. C.LIB

Nova Mentis Life Science Corp is a Canadian-based company focused on building and supporting a diversified portfolio of health and wellness businesses. Through its subsidiary, the company is focused on exploring the anti-inflammatory effects of psilocybin in underexplored metabolic indications such as obesity and diabetes and providing a Health Canada Standard Licensed facility focused on the cultivation of AAAA premium, small batch, terpene rich dominant cultivars cured to perfection.


CSE:LIB - Post by User

Comment by Bellseyon Jan 21, 2018 5:09pm
144 Views
Post# 27404561

RE:RE:Private Placement

RE:RE:Private PlacementI don't understand the warrants at 60 cents (20 cents under our current price). Maybe this was all set up weeks ago when we were in the 40 cents. Harder to accept now that we are 70 cents to a dollar range. Look forward to hearing what others here think. 

Busyzzindahouse wrote: Hmmm..... that was kinda slipped at the end of the day. Not sure what to make of this. 

https://thecse.com/sites/default/files/2018_01_19_Form_9_-_Notice_of_NBPP.pdf


Total amount of funds to be raised: $2,000,000

2. Provide full details of the use of the proceeds. The disclosure should be sufficiently complete to enable a reader to appreciate the significance of the transaction without reference to any other material. . General working capital purposes, seeking out revenue generating cannabis related ventures and North Road Ventures (wholly-owned subsidiary of the Company) ACMPR build-out costs.

Description of securities to be issued:
(a) Class Common Shares (the “Shares) (b) Number 5,000,000 Shares (c) Price per security $0.40 per Unit

Warrants:
(a) Number 2,500,000 Warrants (b) Number of securities eligible to be purchased on exercise of Warrants (or options) 2,500,000 Warrant Shares (c) Exercise price $0.60 (d) Expiry date 2 years from closing


[/quote]

<< Previous
Bullboard Posts
Next >>